The overexpression of CCL2 derived from HER2-positive gastric cancer cells caused a decrease in M1 TAMs density and recruited the M2-like phenotype of TAMs, thereby promoting resistance to trastuzumab. Here, ERBB2 is linked to gastric cancer.